Abstract:Retroviral integration into the host genome is not entirely random, and integration site preferences vary among different retroviruses. Human immunodeficiency virus (HIV) prefers to integrate within active genes, whereas murine leukemia virus (MLV) prefers to integrate near transcription start sites and CpG islands. On the other hand, integration of avian sarcoma-leukosis virus (ASLV) shows little preference either for genes, transcription start sites, or CpG islands. While host cellular factors play important roles in target site selection, the viral integrase is probably the major viral determinant. It is reasonable to hypothesize that retroviruses with similar integrases have similar preferences for target site selection. Although integration profiles are well defined for members of the lentivirus, spumaretrovirus, alpharetrovirus, and gammaretrovirus genera, no members of the deltaretroviruses, for example, human T-cell leukemia virus type 1 (HTLV-1), have been evaluated. We have mapped 541 HTLV-1 integration sites in human HeLa cells and show that HTLV-1, like ASLV, does not specifically target transcription units and transcription start sites. Comparing the integration sites of HTLV-1 with those of ASLV, HIV, simian immunodeficiency virus, MLV, and foamy virus, we show that global and local integration site preferences correlate with the sequence/structure of virus-encoded integrases, supporting the idea that integrase is the major determinant of retroviral integration site selection. Our results suggest that the global integration profiles of other retroviruses could be predicted from phylogenetic comparisons of the integrase proteins. Our results show that retroviruses that engender different insertional mutagenesis risks can have similar integration profiles.

Molecular genetics and target site specificity of retroviral integration.

Site-specific integration of retroviral DNA in human cells using fusion proteins consisting of human immunodeficiency virus type 1 integrase and the designed polydactyl zinc-finger protein E2C.

Role of the Nonspecific DNA-binding Region and Α Helices Within the Core Domain of Retroviral Integrase in Selecting Target DNA Sites for Integration

Human T-cell Leukemia Virus Type 1 Integration Target Sites in the Human Genome: Comparison with Those of Other Retroviruses.

393. Site-Directed Integration in Human Genome by Lentiviral Vectors Containing HIV-1 Integrase/Polydactyl Zinc Finger Fusion Proteins

B-to-A transition in target DNA during retroviral integration

Physical Principles of Retroviral Integration in the Human Genome

Central Core Domain of Retroviral Integrase Is Responsible for Target Site Selection

Integrase-deficient lentivirus: opportunities and challenges for human gene therapy.

A High-Throughput Method for Cloning and Sequencing HIV-1 Integration Sites

A High-Throughput Method for Cloning and Sequencing Human Immunodeficiency Virus Type 1 Integration Sites

Retroviral intasomes search for a target DNA by 1D diffusion which rarely results in integration

Correct Integration Mediated by Integrase–LexA Fusion Proteins Incorporated into HIV-1

Integrase Move‐In Day: Mechanisms of HIV DNA Integration

3'-end processing and kinetics of 5'-end joining during retroviral integration in vivo.

Rigrag: High-Resolution Mapping of Genic Targeting Preferences During HIV-1 Integration in Vitro and in Vivo

Sequence-specific binding of DNA by the Moloney murine leukemia virus integrase protein

Fusion Proteins Consisting of Human Immunodeficiency Virus Type 1 Integrase and the Designed Polydactyl Zinc Finger Protein E2c Direct Integration of Viral Dna into Specific Sites

Retroviral hybrid LTR vector strategy: functional analysis of LTR elements and generation of endothelial cell specificity

Integration Site Analysis in Gene Therapy Patients: Expectations and Reality.

Brief Histories of Retroviral Integration Research and Associated International Conferences